Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
Thermo Fisher Scientific Inc banner

Thermo Fisher Scientific Inc
NYSE:TMO

Watchlist Manager
Thermo Fisher Scientific Inc Logo
Thermo Fisher Scientific Inc
NYSE:TMO
Watchlist
Price: 504.65 USD -1.01% Market Closed
Market Cap: $189.6B
Write Note Create Alert Ask AI
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

TMO Price Targets Summary
Thermo Fisher Scientific Inc

Wall Street analysts forecast TMO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TMO is 678.16 USD with a low forecast of 600.95 USD and a high forecast of 787.5 USD.

TMO Lowest Forecast
Wall Street Target
600.95 USD
19% Upside
TMO Average Forecast
Wall Street Target
678.16 USD
34% Upside
TMO Highest Forecast
Wall Street Target
787.5 USD
56% Upside
Lowest
Price Target
600.95 USD
19% Upside
Average
Price Target
678.16 USD
34% Upside
Highest
Price Target
787.5 USD
56% Upside
Thermo Fisher Scientific Inc Competitors:
Price Targets

Revenue
Forecast

10% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss
10% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss

For the last 14 years the compound annual growth rate for Thermo Fisher Scientific Inc's revenue is 10%. The projected CAGR for the next 3 years is 6%.

What are analyst estimates?

Operating Income
Forecast

14% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-31%
Average Miss
14% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-31%
Average Miss

For the last 14 years the compound annual growth rate for Thermo Fisher Scientific Inc's operating income is 14%. The projected CAGR for the next 3 years is 16%.

What are analyst estimates?

Net Income
Forecast

12% / Year
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-27%
Average Miss
12% / Year
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-27%
Average Miss

For the last 14 years the compound annual growth rate for Thermo Fisher Scientific Inc's net income is 12%. The projected CAGR for the next 3 years is 19%.

What are analyst estimates?

See Also

Summary
TMO intrinsic value, competitors valuation, and company profile.
DCF Valuation
TMO stock valuation using Discount Cash Flow valuation method.
Relative Valuation
TMO stock valuation using valuation multiples.
Wall Street Estimates
TMO price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
TMO stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TMO's stock price target?
Price Target
678.16 USD

According to Wall Street analysts, the average 1-year price target for TMO is 678.16 USD with a low forecast of 600.95 USD and a high forecast of 787.5 USD.

What is Thermo Fisher Scientific Inc's Revenue forecast?
Projected CAGR
6%

For the last 14 years the compound annual growth rate for Thermo Fisher Scientific Inc's revenue is 10%. The projected CAGR for the next 3 years is 6%.

What is Thermo Fisher Scientific Inc's Operating Income forecast?
Projected CAGR
16%

For the last 14 years the compound annual growth rate for Thermo Fisher Scientific Inc's operating income is 14%. The projected CAGR for the next 3 years is 16%.

What is Thermo Fisher Scientific Inc's Net Income forecast?
Projected CAGR
19%

For the last 14 years the compound annual growth rate for Thermo Fisher Scientific Inc's net income is 12%. The projected CAGR for the next 3 years is 19%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 317,600+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.